Immune Endotyping Enables Risk Stratification in Type 2 Diabetes
At the EASD 2026 conference, researchers presented findings on immune endotyping as a method to stratify risk in Type 2 Diabetes (T2D) patients. This approach helps identify different immune profiles among T2D individuals, potentially improving personalized treatment and management strategies for the disease.
European Medical Journal·8h ago


